Geode Capital Management
ACUR

Geode Capital Management’s Acura Pharmaceuticals ACUR Stock Holding History

Geode Capital Management’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-21,129
Closed -$16K – 4129
2016
Q4 		$16K Buy
21,129
+84
+0.4% +$88 ﹤0.01% 4016
2016
Q3 		$33K Buy
21,045
+21
+0.1% +$37 ﹤0.01% 3961
2016
Q2 		$38K Hold
21,024
– – ﹤0.01% 3971
2016
Q1 		$59 Sell
21,024
-21
-0.1% -$45 ﹤0.01% 3947
2015
Q4 		$53K Buy
21,045
+42
+0.2% +$102 ﹤0.01% 3993
2015
Q3 		$49K Buy
21,003
+41
+0.2% +$139 ﹤0.01% 4015
2015
Q2 		$103K Buy
20,962
+21
+0.1% +$87 ﹤0.01% 3765
2015
Q1 		$82K Buy
20,941
+65
+0.3% +$207 ﹤0.01% 3791
2014
Q4 		$46K Buy
20,876
+64
+0.3% +$177 ﹤0.01% 3893
2014
Q3 		$81K Buy
20,812
+43
+0.2% +$202 ﹤0.01% 3784
2014
Q2 		$113K Sell
20,769
-22
-0.1% -$133 ﹤0.01% 3671
2014
Q1 		$151K Buy
20,791
+64
+0.3% +$556 ﹤0.01% 3569
2013
Q4 		$173K Buy
20,727
+43
+0.2% +$363 ﹤0.01% 3474
2013
Q3 		$196K Buy
20,684
+8,957
+76% +$79.2K ﹤0.01% 3316
2013
Q2 		$110K Buy
+11,727
New +$132K ﹤0.01% 3406

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Geode Capital Management's ACUR Position: Q1 2017 in Review

Geode Capital Management sold out of Acura Pharmaceuticals (ACUR) in Q1 2017, closing a stake of 21,129 shares — an estimated $16K sold.

Geode Capital Management first reported a position in ACUR in Q2 2013 and held it in 15 quarters. The position peaked at $196K in Q3 2013. 3 funds tracked by Wall St. Rank hold ACUR as of Q1 2017.

  • Geode Capital Management reported no remaining Acura Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Geode Capital Management sold 21,129 Acura Pharmaceuticals shares in Q1 2017, an estimated $16K.
  • Geode Capital Management first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Geode Capital Management's Acura Pharmaceuticals position peaked at $196K in Q3 2013.
  • 3 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2017.

Based on Geode Capital Management's 13F filing for Q1 2017, filed 12 May 2017.